Top 5 Takeaways Prevalence of Stigma and Discrimination: Hispanic or Latino persons with HIV reported high levels of stigma and health care discrimination, with women and American Indian or Alaska
Tag: 2022
Top 5 Takeaways High Prevalence of ACEs: During the COVID-19 pandemic, 73.1% of U.S. high school students reported at least one Adverse Childhood Experience (ACE), with 7.8% reporting four or
Top 5 Takeaways First Reported U.S. Case of Monkeypox from Needlestick in Healthcare: A nurse in Florida contracted monkeypox from a needlestick injury while collecting a swab from a patient’s
Top 5 Takeaways Effectiveness of Monovalent mRNA Vaccines: During the SARS-CoV-2 Omicron BA.1/BA.2 and BA.4/BA.5 periods, the effectiveness of three-dose monovalent mRNA vaccines against COVID-19–associated hospitalization waned over time. Vaccine
Top 5 Takeaways Vaccine Effectiveness (VE): Among immunocompromised adults, the VE of 2-dose monovalent mRNA COVID-19 vaccines against hospitalization during Omicron predominance was 36%. VE increased to 67% after a
Top 5 Takeaways This report details five cases of ocular monkeypox in the U.S. from July to September 2022, highlighting serious complications including vision impairment and prolonged illness. Patients with
Top 5 Takeaways Oral Antivirals for COVID-19: The study analyzes the dispensing of oral antiviral drugs, Paxlovid and Lagevrio, for COVID-19 treatment, focusing on zip code-level social vulnerability in the
Top 5 Takeaways Pronounced Disparities: From April to July 2022, Paxlovid treatment among COVID-19 patients aged ≥20 years was significantly lower for Black (35.8% less) and Hispanic (29.9% less) patients
Top 5 Takeaways Influenza A(H3N2) virus, specifically clade 3C.2a1b.2a.2, emerged in Chile much earlier than in pre-pandemic seasons, resulting in 1,002 hospitalizations in 2022. The influenza vaccination was found to
Top 5 Takeaways Among 57 patients hospitalized for severe monkeypox during the study period, most were Black men with AIDS, highlighting the severe impact of monkeypox in immunocompromised individuals. Twelve